mrcm.org.uk

PCR, Host Biomarkers, LAMP and Metagenomic Sequencing in Invasive Fungal Disease Professional Evidence Brief | MRCM Weekly Literature Review Key

Key Points Contents Overall Summary This week’s fungal diagnostics update highlights the growing importance of tests that can provide useful

Week Commencing 8 June 2026 Audience: Clinical microbiologists, infectious disease physicians, respiratory physicians, haematologists, transplant specialists, laboratory scientists and diagnostic

Reviewing recent developments in molecular diagnostics, biomarkers and rapid testing for invasive fungal disease Introduction The fungal diagnostics landscape continues

Executive summary: The 2026 UK Infection-Specialist Workforce Report represents an important strategic shift for medical mycology and fungal disease services.

Audience: patients, carers, non-specialist clinicians and laboratory colleagues interested in fungal disease diagnostics. Last reviewed: 18 May 2026 Key points

This week’s fungal diagnostics search identified new papers on sequencing-based diagnosis, fungal biomarkers, species identification, antifungal susceptibility testing, and candidemia

Date: 5 May 2026 This week’s update highlights advances across fungal diagnostics, particularly in Aspergillus testing, emerging biomarkers, molecular diagnostics,

Last reviewed: April 2026 Key Points Rapid molecular diagnostics (PCR, LAMP, metagenomic sequencing) are expanding quickly. No single test is

Last reviewed: 20 April 2026 This week’s fungal diagnostics papers highlight a clear pattern: tests are becoming broader, faster, and